Emmanuel Di Valentin

University of Liège — Belgium

Medicine · Health Sciences

31h-index4.7kcitations98works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Herpesvirus Infections and Treatments(13), Protein Kinase Regulation and GTPase Signaling(11), CAR-T cell therapy research(11), Cancer Immunotherapy and Biomarkers(8), Virus-based gene therapy research(7)

Publications97 total

Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma
Cells·2025Open Access
Design d'un nouveau NanoCAR qui est comparable à un CAR conventionnel composé d'une partie ScFv, les 2 ciblant BCMA dans le myélome multiple
Open Repository and Bibliography (University of Liège)·2025Open Access
1307 ICT01, a γ9δ2 T-cell-activating mAb, in combination with pembrolizumab elicits deep and durable responses in second-line patients with primary refractory melanoma: Results from EVICTION study
2025Open Access
Tanycytic annexinA1-containing extracellular vesicles control thermogenesis by orchestrating microglial and neuronal functions
2025· 1 citedOpen Access
Design of a novel NanoCAR construct that compares well with a conventional ScFv-based CAR targeting BCMA on multiple myeloma
2025Open Access
DEVELOPMENT AND VALIDATION OF A NEW PTK7-TARGETED AAV-MEDIATED SUICIDE-GENE THERAPY FOR GLIOBLASTOMA
Neuro-Oncology·2025Open Access
SARS-CoV2 infection triggers inflammatory conditions and astrogliosis-related gene expression in long-term human cortical organoids
Stem Cells·2025· 2 citedOpen Access
692 ICT01 and pembrolizumab in combination elicit deep and durable responses in heavily pretreated patients with refractory melanoma: interim results from study EVICTION
Regular and Young Investigator Award Abstracts·2024Open Access
641 ICT01 and pembrolizumab in combination elicit deep and durable responses in heavily pretreated patients with urothelial cell carcinoma: interim results from study EVICTION
Regular and Young Investigator Award Abstracts·2024Open Access
Development of an intraventricular Adeno-Associated Virus-based labelling strategy for glioblastoma cells nested in the subventricular zone
Neuro-Oncology Advances·2024Open Access
EVICTION study: ICT01, an anti-Butyrophilin 3A monoclonal antibody activating γ9δ2 T cells in combination with pembrolizumab in checkpoint inhibitor refractory melanoma.
Journal of Clinical Oncology·2024· 3 cited
Production et développement d'une nouvelle immunothérapie ciblant le myélome multiple
Open Repository and Bibliography (University of Liège)·2024
SARS-CoV2 infection triggers reactive astrocyte states and inflammatory conditions in long-term Human Cortical Organoids
2024· 1 citedOpen Access
822O Activation of γ9δ2 T cells by ICT01 as a novel immunotherapeutic approach for relapsed/refractory hematologic cancers (EVICTION trial)
Annals of Oncology·2023· 2 citedOpen Access
The helicase-like transcription factor redirects the autophagic flux and restricts human T cell leukemia virus type 1 infection
Proceedings of the National Academy of Sciences·2023· 5 citedOpen Access
Severe Acute Respiratory Syndrome Coronavirus 2 detection in induced sputum of asthmatic patients using saliva sampling device
2022
Abstract CT188: ICT01, an anti-butyrophilin 3A targeted mAb activating g9d2 T cells, induces immune remodeling of the tumor microenvironment and clinical responses in combination with pembrolizumab in patients with advanced solid tumors who failed prior checkpoint inhibitor therapy: EVICTION Trial
Cancer Research·2022· 2 cited
"Switch-off the trouble: DMPK promoter targeting by CRISPRi as an original specific therapy in DM1"
HAL (Le Centre pour la Communication Scientifique Directe)·2022
Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy
International Journal of Molecular Sciences·2022· 12 citedOpen Access
STEM-25. ADENO-ASSOCIATED VIRUS INTRAVENTRICULAR INJECTION ALLOWS THE RESTRICTED TRANSDUCTION OF GLIOBLASTOMA CELLS NESTED IN THE PERI- AND SUB-VENTRICULAR ZONE IN A PATIENT-DERIVED ORTHOTOPIC XENOGRAFT MODEL
Neuro-Oncology·2021Open Access
page 1 of 5Next →

Frequent Co-authors

Gérard Lambeau(12), Jacques Piette(10), Michael H. Gelb(9), Farideh Ghomashchi(7), Michel Lazdunski(7), Philippe Delvenne(6), Catherine Sadzot‐Delvaux(6), Jacques Piette(6), Arnaud Blomme(5), Brunella Costanza(5), Akeila Bellahcène(5), Andrei Turtoï(5), Yvette Habraken(5), Sébastien Bontems(5), Rao S. Koduri(4), Didier Cataldo(4), Vincent Castronovo(4), Nicolas Goffart(4), Bernard Rogister(4), Marc Thiry(4)